Schedule 13G ownership disclosure
ANIKA THERAPEUTICS INC
Common Stock · CUSIP: 035255108
Event date: 2024-12-31
- Filing-level shares
- 657,355.00
- Percent of class
- 4.5%
- Dimensional Fund Advisors LP
Shares: 657,355.00 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000354204-25-000493
- Form type
- SCHEDULE 13G/A
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Jan 23, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership